Obulytix

Skip to content

CHECKED

Companies Insolvencies Sectors Watchlist Alerts API

Sign in

Obulytix

Gent ·KBO/BCE: BE 0803.351.624

Loading dossier…

Checked · Insight, alerts and connections for every Belgian company, from official sources.

NL FR EN

Product

Search companies Sectors Radar Live Compare Prospects Supplier check Feasibility Decision tools Company map

Data & registers

Insolvencies Curators Directors Director bans Protection orders Notaries News

Account

Watchlist Portfolio Alerts Pricing

Checked

About Methodology Knowledge base Sources FAQ Help API Developers Badge Business information compared Free company information

Legal

Privacy Terms Contact

Checked AI

Open a company dossier to ask Checked AI about it.

Your question travels, with the dossier's public data, to our AI model at Anthropic in the US. Nothing that identifies you goes along, and we keep neither question nor answer. Answers can be wrong, so this is not legal advice. How it works

Metric	This company	Sector median	Position in the sector
Solvency	74.9%	46.9%	better than 70% of 46 sector peers
Net result	€-1.08M	€-1k	better than 12% of 46 sector peers
Equity	€3.82M	€108k	better than 84% of 46 sector peers
Gross operating margin	€-590k	€28k	better than 5% of 42 sector peers
Total assets	€5.10M	€284k	better than 85% of 46 sector peers

Fiscal year	2024
Revenue	-
EBITDA	€-843k
Net profit	€-1.08M
Cash flow	€-827k
Staff costs	€253k
Income taxes	-
Dividends	-
Total assets	€5.10M
Equity	€3.82M
Debt	€1.28M
of which ≤ 1y	€342k
of which > 1y	-
Working capital	€2.74M
Employees (FTE)	2.6

	2024
Current ratio	9.00
Quick ratio	9.00
Working capital ratio	53.6%
Solvency	74.9%
Debt / equity	0.34
Long-term debt ratio	-
Interest coverage	-712.21
Gross margin	-
Net margin	-
ROA	-21.2%
ROE	-28.3%
EBITDA margin	-
Days sales outstanding	-
Days payable outstanding	-
Inventory turnover	-
Days inventory (DSI)	-

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€5.10M
Fixed assets	21/28	€1.97M
Formation expenses	20	€51k
Intangible fixed assets	21	€1.75M
Tangible fixed assets	22/27	€222k
Current assets	29/58	€3.08M
Amounts receivable within one year	40/41	€580k
Cash & bank	54/58	€1.51M
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€5.10M
Equity	10/15	€3.82M
Contributions / capital	10/11	€4.67M
Accumulated profits (losses)	14	€-1.08M
Amounts payable	17/49	€1.28M
Amounts payable within one year	42/48	€342k
Trade debts payable within one year	44	€315k
Income statement
Gross operating margin	9900	€-590k
Operating result	9901	€-1.10M
Financial income	75	€17k
Financial charges	65	€1k
Result before taxes	9903	€-1.08M
Net result for the period	9904	€-1.08M
Result to be appropriated	9905	€-1.08M

NACE primary	Vervaardiging van geneesmiddelen(21201)
Legal form	Private limited company(610)
Incorporation	29-06-2023
Status	Active
Postal code	9052

Summary

Conclusion

Trust signals

Administrative Flags

Bankruptcy probability (12 mo)

Financials

Annual accounts & ratios

Health barometer

Directors

Directors & mandates

Statutory auditor

Insolvency mandates

Legal Structure

Structure & network

Connections & network

Locations & real estate

Registered office

Establishment units

Real-estate footprint

Publications

Lifecycle & Insolvency Signals

Belgisch Staatsblad · acts

Analysis

Snowflake analysis

Ask AI about this company

AI due-diligence brief

Credit advice

Similar

Similar companies

Company registry

Company registry (CBE)